Measles Seropositivity in HIV-Infected Kenyan Children on Antiretroviral Therapy.

Citation:
Newman LP, Njoroge A, Ben-Youssef L, Merkel M GA, Ton Q, Obimbo EM WD, Lohman-Payne B, Nduati R, Obimbo E. "Measles Seropositivity in HIV-Infected Kenyan Children on Antiretroviral Therapy." Pediatr Infect Dis J. 2014 Mar 10. [Epub ahead of print] PMID: 24618938 [PubMed - as supplied by publisher] . 2014.

Abstract:

1. Pediatr Infect Dis J. 2014 Mar 10. [Epub ahead of print]

Measles Seropositivity in HIV-Infected Kenyan Children on Antiretroviral Therapy.

Newman LP(1), Njoroge A, Ben-Youssef L, Merkel M, Gatuguta A, Ton Q, Obimbo EM,
Wamalwa D, Lohman-Payne B, Richardson BA, Nduati R, Farquhar C.

Author information:
(1)a Department of Epidemiology, c Department of Medicine, g Department of Global
Health, e Department of Biostatistics, University of Washington, Seattle, WA, USA
b Department of Public Health, d Department of Paediatrics and Child Health,
University of Nairobi, Nairobi, Kenya f Division of Vaccine and Infectious
Disease, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

This paper describes results from a cross-sectional study among HIV-infected
children 15 months to 12 years of age who were receiving antiretroviral therapy.
We found a low prevalence of measles IgG seropositivity (45.7%) and identified
CD4% ≥ 25 as a predictor. Most HIV-infected children on ART were not measles
seropositive and might benefit from revaccination.

PMID: 24618938 [PubMed - as supplied by publisher]

UoN Websites Search